[go: up one dir, main page]

PE20030386A1 - Compuestos de octahidrofenantreno sustituidos, procedimientos para su preparacion, medicamentos que contienen estos compuestos y el uso de los compuestos para la preparacion de medicamentos - Google Patents

Compuestos de octahidrofenantreno sustituidos, procedimientos para su preparacion, medicamentos que contienen estos compuestos y el uso de los compuestos para la preparacion de medicamentos

Info

Publication number
PE20030386A1
PE20030386A1 PE2002000735A PE2002000735A PE20030386A1 PE 20030386 A1 PE20030386 A1 PE 20030386A1 PE 2002000735 A PE2002000735 A PE 2002000735A PE 2002000735 A PE2002000735 A PE 2002000735A PE 20030386 A1 PE20030386 A1 PE 20030386A1
Authority
PE
Peru
Prior art keywords
compounds
preparation
medicines
octahydrophenantrene
dimethylaminomethyl
Prior art date
Application number
PE2002000735A
Other languages
English (en)
Inventor
Michael Sattlegger
Michael Przewosny
Helmut Buschmann
Werner Englberger
Hans Schick
Brigitta Henkel
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of PE20030386A1 publication Critical patent/PE20030386A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/48Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
    • C07C215/50Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups with amino groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/31Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the six-membered aromatic ring being part of a condensed ring system formed by at least three rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/58Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms with amino groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/26Phenanthrenes; Hydrogenated phenanthrenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE REFIERE A COMPUESTOS OCTAHIDROFENANTRONA SUSTITUIDOS DE FORMULA I DONDE R0, R1, R2 SON H, RADICAL ALIFATICO C1-C12, CICLOALIFATICO C3-C7, ARILO, HETEROARILO; R3 Y R4 SON H, RADICAL ALIFATICO C1-C12, RADICAL CICLOALIFATICO C3-C7, ARILO, HETEROARILO O FORMAN UN CICLO (CH2)(2-7); R5 ES RADICAL ALIFATICO C1-C12, CICLOALIFATICO C3-C7, ARILO, HETEROARILO. SON COMPUESTOS PREFERIDOS 8-DIMETILAMINOMETIL-4b,5,6,7,8,8a,9,10-OCTAHIDROFENANTRENO; 8-DIMETILAMINOMETIL-3-METOXI-4b,5,6,7,8,8a,9,10-OCTAHIDROFENANTRENO; 8-DIMETILAMINOMETIL-4b,5,6,7,8,8a,9,10-OCTAHIDROFENANTRENO-3-OL; 8-DIMETILAMINOMETIL-2-FLUORO-4b,5,6,7,8,8a,9,10-OCTAHIDROFENANTRENO, ENTRE OTROS. TAMBIEN SE REFIERE A UN PROCESO PARA LA PREPARACION. LOS COMPUESTOS SON ANTAGONISTAS DE NMDA AL TENER AFINIDAD POR EL PUNTO DE ENLACE (+)-MK801 DEL CANAL IONICO NMDA Y PUEDEN SER UTILES PARA TRATAMIENTO DE DOLOR CRONICO O NEUROPATICO, ENFERMEDADES NEURODEGENERATIVAS, ALZHEIMER, PARKINSON, HUNTINGTON, ISQUEMIA CEREBRAL, INFARTO CEREBRAL, ESQUIZOFRENIA
PE2002000735A 2001-08-16 2002-08-15 Compuestos de octahidrofenantreno sustituidos, procedimientos para su preparacion, medicamentos que contienen estos compuestos y el uso de los compuestos para la preparacion de medicamentos PE20030386A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10140213A DE10140213A1 (de) 2001-08-16 2001-08-16 Substituierte Octahydrophenanthren-Verbindungen

Publications (1)

Publication Number Publication Date
PE20030386A1 true PE20030386A1 (es) 2003-06-07

Family

ID=7695638

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2002000735A PE20030386A1 (es) 2001-08-16 2002-08-15 Compuestos de octahidrofenantreno sustituidos, procedimientos para su preparacion, medicamentos que contienen estos compuestos y el uso de los compuestos para la preparacion de medicamentos

Country Status (6)

Country Link
US (1) US20040162432A1 (es)
EP (1) EP1423353A1 (es)
AR (1) AR036262A1 (es)
DE (1) DE10140213A1 (es)
PE (1) PE20030386A1 (es)
WO (1) WO2003016261A1 (es)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2750382A (en) * 1953-12-03 1956-06-12 Searle & Co Basic esters of 1, 12-dimethyl-6-alkoxy-1, 2, 3, 4, 9, 10, 11, 12-octahydrophenanthrene-1-carboxylic acids
US3269833A (en) * 1965-03-26 1966-08-30 Bendix Corp Chromium-iron alloy
US4786720A (en) * 1986-07-25 1988-11-22 Westvaco Corporation Sulfomethylated lignin amines
US5041477A (en) * 1989-09-07 1991-08-20 Basf Corporation Oligomeric aromatic dispersing agents, method of making same, and dispersions made therefrom
CA2111138A1 (en) * 1993-01-15 1994-07-16 Thierry Godel Octahydrophenanthrene derivatives
CN1113943C (zh) * 1997-04-11 2003-07-09 中国林业科学研究院林产化学工业研究所 松香基季铵盐类化合物及其制备方法

Also Published As

Publication number Publication date
US20040162432A1 (en) 2004-08-19
WO2003016261A1 (de) 2003-02-27
EP1423353A1 (de) 2004-06-02
DE10140213A1 (de) 2003-02-27
AR036262A1 (es) 2004-08-25

Similar Documents

Publication Publication Date Title
AR041566A1 (es) Derivados de indol utiles para el tratamiento de enfermedades
BG93979A (bg) Производни на n-(4-пиперидинил)(дихидробензофуран или дихидро-2н-бензопиран)карбоксамид, фармацевтичен състав, който ги съдържа, метод за получаване на производните и приложението им
ATE381542T1 (de) Nr1h4-kern-rezeptor-bindende verbindungen
SE0104334D0 (sv) Therapeutic agents
ES2034893A1 (es) Procedimiento para la obtencion de nuevos pregna-1,4-diene-3,20-dione-16-17-acetal-21 esteres.
IL156751A0 (en) Substituted alkylamine derivatives and methods of use
ES2147759T3 (es) Heterociclos no aromaticos sustituidos con aminometileno y uso como antagonistas de la sustancia p.
EA200301216A1 (ru) Замещенные хинуклидинами мультициклические гетероарилы для лечения заболевания
NO168372C (no) Fremgangsmaate for fremstilling av terapeutisk aktive tricykloforbindelser
BR0017028A (pt) Lipopepìdeos como agentes antibacterianos
HUP0302474A2 (hu) Terápiásan hatásos tropánszármazékok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
SE0104332D0 (sv) Therapeutic agents
BR0017026A (pt) Lipeptìdeos como agentes antibacterianos
FI913478A0 (fi) Diazinderivat.
TW200502221A (en) Novel lactams and uses thereof
DK0587088T3 (da) Substituerede cyclohexan-derivater, fremgangsmåde til deres fremstilling og anvendelsen af forbindelserne til behandling af sygdomme
UY27593A1 (es) Nuevos compuestos
MXPA05011294A (es) Compuestos de fosfonato anti-inflamatorios.
ATE243215T1 (de) Neue 2-decarboxy-2-phosphinico prostaglandin f analoge
AR032622A1 (es) Compuestos de 4-amino-azepan-3-ona, composiciones farmaceuticas que los comprenden, intermediarios utiles en la sintesis de tales compuestos, procedimiento para la sintesis de dichos compuestos, y uso de tales compuestos en la fabricacion de medicamentos
DK469687D0 (da) Derivater af 4,5-dihydrooxazoler og fremgangsmaade til fremstilling af saadanne derivater.
PE20030386A1 (es) Compuestos de octahidrofenantreno sustituidos, procedimientos para su preparacion, medicamentos que contienen estos compuestos y el uso de los compuestos para la preparacion de medicamentos
AR036092A1 (es) Un derivado de benzoxazepina, su uso y una composicion farmaceutica que lo comprende
PE20251750A1 (es) Inhibidores de hexahidro-2h-pirido[2,1-a]isoquinolina vmat2 y metodos de uso
PA8525601A1 (es) Profarmacos de (3s,4s)-4-bencil-1-[2-(4-hidroxi-bencenosulfonil)-etil]-piperidin-3-ol

Legal Events

Date Code Title Description
FD Application declared void or lapsed